Saturday, June 9

Meet-the-Expert | Clinical Trial Update | Science in Progress | Simultaneous Sessions I | Hematolgy-in-Focus Session | Clinical Trial Update | Simultaneous Sessions II | Lunch Debate | EHA / ASH Joint Symposium on Stem Cell Banking | EHA Business Meeting | Presidential Symposium | Plenary Session I | Poster Session II

CLINICAL TRIAL UPDATE

10.30-11.45 hours, Room: Strauss I

RANDOMIZED TRIALS IN HEMOPHILIA AND VON WILLEBRAND DISEASE

Chair: P. Mannucci (University of Milan, Milan, Italy)

IMMUNE TOLERANCE IN PATIENTS WITH FACTOR VIII INHIBITORS: THE ITI STUDY AND ASSOCIATED PROTOCOLS

C. Hay (University Department of Haematology, Manchester, United Kingdom)

FACTOR VIII INHIBITORS AND TYPE OF REPLACEMENT THERAPY: THE SIPPET TRIAL OF RECOMBINANT VS PLASMA DERIVED FACTOR

P. Mannucci (A. Bianchi Bonomi Center, Milan, Italy)

TRIALS IN VON WILLEBRAND DISEASE (VWD PN, PROWILL)

E. Berntorp (Lund University, Malmö, Sweden) K DISCUSSION
Top of page ]


EHA Executive Office, Westblaak 71, 3012 KE Rotterdam, The Netherlands | Phone: (+31) 10-4361760 | Email: